ORCID as entered in ROS
![orcid_icon](/themes/resgate8/images/icons/ORCIDiD_icon24x24.png)
Select Publications
2022, 'The authors reply', Kidney International, 101, pp. 187 - 187, http://dx.doi.org/10.1016/j.kint.2021.11.010
,2022, 'The environment and kidney health: challenges and opportunities', Salud Publica de Mexico, 64, pp. 46 - 55, http://dx.doi.org/10.21149/12799
,2022, 'The Indian Chronic Kidney Disease (ICKD) study: baseline characteristics', Clinical Kidney Journal, 15, pp. 60 - 69, http://dx.doi.org/10.1093/ckj/sfab149
,2022, 'Treatment preferences for primary membranous nephropathy: Results of a multinational survey among nephrologists in the South Asia Pacific region', Nephrology, 27, pp. 35 - 43, http://dx.doi.org/10.1111/nep.13953
,2022, 'World wellbeing watch', The BMJ, http://dx.doi.org/10.1136/bmj.o800
,2022, 'Anti-PLA2R Autoantibodies and Clinical Activity in Patients With Primary Membranous Nephropathy', Journal of the American Society of Nephrology, 33, pp. 949 - 950, http://dx.doi.org/10.1681/asn.20223311s1949d
,2022, 'Challenges in Diagnosis and Management of Glomerular Disease in a Resource-Limited Setting', Journal of the American Society of Nephrology, 33, pp. 180 - 180, http://dx.doi.org/10.1681/asn.20223311s1180b
,2022, 'Community Perception of Chronic Kidney Disease in Supebeda, Chhattisgarh', International Journal of Current Research and Review, 14, pp. 23 - 28, http://dx.doi.org/10.31782/ijcrr.2022.14210
,2022, 'Environmental change and kidney health', Wits Journal of Clinical Medicine, 4, pp. 141 - 141, http://dx.doi.org/10.18772/26180197.2022.v4n3a3
,2022, 'Erythropoiesis-Stimulating Agent Hyporesponsiveness and Anemia Management in the ASCEND-D Trial', Journal of the American Society of Nephrology, 33, pp. 242 - 242, http://dx.doi.org/10.1681/asn.20223311s1242a
,2022, 'Gender Disparity in CKD: Men From Mars, Women From Venus', Journal of the American Society of Nephrology, 33, pp. 567 - 568, http://dx.doi.org/10.1681/asn.20223311s1567c
,2022, 'Hemoglobin Stability in the ASCEND-D and -ND Trials', Journal of the American Society of Nephrology, 33, pp. 244 - 244, http://dx.doi.org/10.1681/asn.20223311s1244b
,2022, 'Identification of Neglected Kidney Diseases: Results From an International Survey', Journal of the American Society of Nephrology, 33, pp. 569 - 569, http://dx.doi.org/10.1681/asn.20223311s1569b
,2022, 'Immunosuppression Practices in Failing Renal Allografts: A South Asian Perspective', Journal of the American Society of Nephrology, 33, pp. 558 - 558, http://dx.doi.org/10.1681/asn.20223311s1558c
,2022, 'Longitudinally extensive transverse myelitis following ChAdOx1 nCoV-19 vaccine.', J Postgrad Med, 68, pp. 179 - 181, http://dx.doi.org/10.4103/jpgm.jpgm_1047_21
,2022, 'Outcomes Differences in User vs. Non-User of Renin-Angiotensin Blockers in Early CKD', Journal of the American Society of Nephrology, 33, pp. 853 - 853, http://dx.doi.org/10.1681/asn.20223311s1853a
,2022, 'Performance of Race Neutral CKD-EPI 2021 eGFR Equations in Indian Population', Journal of the American Society of Nephrology, 33, pp. 582 - 582, http://dx.doi.org/10.1681/asn.20223311s1582a
,2022, 'Prophylaxis for Vulnerable Patients at Risk of COVID-19 Infection (PROTECT-V): A Platform Trial Experience', Journal of the American Society of Nephrology, 33, pp. 326 - 326, http://dx.doi.org/10.1681/asn.20223311s1326b
,2022, 'Serum Myo-Inositol Oxygenase Levels at Hospital Discharge Predict Progression to CKD in Community-Acquired AKI', Journal of the American Society of Nephrology, 33, pp. 56 - 56, http://dx.doi.org/10.1681/asn.20223311s156b
,2022, 'Should More Patients with Kidney Failure Bring Treatment Home? What We Have Learned from COVID-19', Kidney diseases (Basel, Switzerland), pp. 1 - 11
,2022, 'Time-Dependent Covariate Analysis of Hemoglobin Values on Risk of Major Adverse Cardiovascular Events in the ASCEND Trials', Journal of the American Society of Nephrology, 33, pp. 44 - 44, http://dx.doi.org/10.1681/asn.20223311s144a
,2021, 'Daprodustat for the treatment of anemia in patients not undergoing dialysis', New England Journal of Medicine, 385, pp. 2313 - 2324, http://dx.doi.org/10.1056/NEJMoa2113380
,2021, 'Daprodustat for the treatment of anemia in patients undergoing dialysis', New England Journal of Medicine, 385, pp. 2325 - 2335, http://dx.doi.org/10.1056/NEJMoa2113379
,2021, 'Assessing the impact of screening, early identification and intervention programmes for chronic kidney disease: Protocol for a scoping review', BMJ Open, 11, http://dx.doi.org/10.1136/bmjopen-2021-053857
,2021, 'Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials', BMC Infectious Diseases, 21, http://dx.doi.org/10.1186/s12879-021-06829-7
,2021, 'Building optimal and sustainable kidney care in low resource settings: The role of healthcare systems', Nephrology, 26, pp. 948 - 960, http://dx.doi.org/10.1111/nep.13935
,2021, 'Humoral Response to One and Two Doses of ChAdOx1-S Vaccine in Patients on Hemodialysis', Clinical Journal of the American Society of Nephrology, 16, pp. 1875 - 1876, http://dx.doi.org/10.2215/CJN.10170721
,2021, 'Increased serum catalytic iron may mediate tissue injury and death in patients with COVID-19', Scientific Reports, 11, http://dx.doi.org/10.1038/s41598-021-99142-x
,2021, 'Membranous nephropathy', Nature Reviews Disease Primers, 7, http://dx.doi.org/10.1038/s41572-021-00303-z
,2021, 'Protocol for the Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease (CLARITY): a randomised controlled trial', Trials, 22, pp. 573, http://dx.doi.org/10.1186/s13063-021-05521-0
,2021, 'The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline Characteristics', American Journal of Nephrology, 52, pp. 827 - 836, http://dx.doi.org/10.1159/000519812
,2021, 'Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive without Life Support in Adults with COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial', JAMA - Journal of the American Medical Association, 326, pp. 1807 - 1817, http://dx.doi.org/10.1001/jama.2021.18295
,2021, 'Challenges in the delivery of critical care in India during the COVID-19 pandemic', Journal of the Intensive Care Society, 22, pp. 342 - 348, http://dx.doi.org/10.1177/1751143720952590
,2021, 'Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia: The COVID STEROID randomised, placebo-controlled trial', Acta Anaesthesiologica Scandinavica, 65, pp. 1421 - 1430, http://dx.doi.org/10.1111/aas.13941
,2021, 'Ongoing and future COVID-19 vaccine clinical trials: challenges and opportunities', The Lancet Infectious Diseases, 21, pp. e342 - e347, http://dx.doi.org/10.1016/S1473-3099(21)00263-2
,2021, 'Peritoneal dialysis: Status report in South and South East Asia', Nephrology, 26, pp. 898 - 906, http://dx.doi.org/10.1111/nep.13949
,2021, 'Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019', The Lancet, 398, pp. 1593 - 1618, http://dx.doi.org/10.1016/S0140-6736(21)01546-4
,2021, 'Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases', Kidney International, 100, pp. 753 - 779, http://dx.doi.org/10.1016/j.kint.2021.05.015
,2021, 'KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases', Kidney International, 100, pp. S1 - S276, http://dx.doi.org/10.1016/j.kint.2021.05.021
,2021, 'Long-Term Follow-Up of Cyclical Cyclophosphamide and Steroids Versus Tacrolimus and Steroids in Primary Membranous Nephropathy', Kidney International Reports, 6, pp. 2653 - 2660, http://dx.doi.org/10.1016/j.ekir.2021.07.028
,2021, 'The High Mortality and Impact of Vaccination on COVID-19 in Hemodialysis Population in India During the Second Wave', Kidney International Reports, 6, pp. 2731, http://dx.doi.org/10.1016/j.ekir.2021.08.004
,2021, 'Итоговое резюме KDIGO 2018 по гепатиту С для рекомендаций по ХБП: достижения в оценке и менеджменте', KIDNEYS, 7, pp. 261 - 268, http://dx.doi.org/10.22141/2307-1257.7.4.2018.148514
,2021, 'Continuous ambulatory peritoneal dialysis peritonitis guidelines - Consensus statement of peritoneal dialysis society of India - 2020', Indian Journal of Nephrology, 31, pp. 425 - 434, http://dx.doi.org/10.4103/ijn.IJN_73_19
,2021, 'Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseases', The Lancet Gastroenterology and Hepatology, 6, pp. 743 - 753, http://dx.doi.org/10.1016/S2468-1253(21)00132-1
,2021, 'Low-value medical care in the pandemic—is this what the doctor ordered?', The Lancet Global Health, 9, pp. e1203 - e1204, http://dx.doi.org/10.1016/S2214-109X(21)00252-7
,2021, 'Outcomes of symptomatic coronavirus disease 19 in maintenance hemodialysis patient in India', Seminars in Dialysis, 34, pp. 360 - 367, http://dx.doi.org/10.1111/sdi.13000
,2021, 'Prescription Practices in Patients With Mild to Moderate CKD in India', Kidney International Reports, 6, pp. 2455 - 2462, http://dx.doi.org/10.1016/j.ekir.2021.06.011
,2021, 'Chronic kidney disease of unknown etiology In India: What do we know and where do we need to go', Kidney International Reports, 6, pp. 2743 - 2751, http://dx.doi.org/10.1016/j.ekir.2021.07.031
,2021, 'COVID-19 and care for patients with chronic kidney disease: Challenges and lessons', FASEB BioAdvances, 3, pp. 569 - 576, http://dx.doi.org/10.1096/fba.2021-00002
,2021, 'Health System Building Blocks and Organ Transplantation in India', Transplantation, 105, pp. 1631 - 1634, http://dx.doi.org/10.1097/TP.0000000000003685
,